Connection

Michael Zile to Sarcoplasmic Reticulum

Back to Details
This is a "connection" page, showing publications Michael Zile has written about Sarcoplasmic Reticulum.
Michael Zile
Connection Strength
0.056
Sarcoplasmic Reticulum
  1. A phase II, double-blind, randomized, placebo-controlled, dose comparative study of the efficacy, tolerability, and safety of MCC-135 in subjects with chronic heart failure, NYHA class II/III (MCC-135-GO1 study): rationale and design. J Card Fail. 2004 Jun; 10(3):193-9.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.